ESWT for Shoulder Pain in Patients With Brain Damage
Study Details
Study Description
Brief Summary
This study aimed to investigate the efficacy and safety of extracorporeal shockwave therapy (ESWT) for upper extremity pain related to spasticity in patients with spinal cord injury.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
6 times of ESWT (3,000 pulses per time, low energy under 0.3 mJ/mm^2, tolerable range) on subscapularis and lesser and greater tuberlces of humerus to reduce pain in patients with brain damage
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Experimental group 3,000 pulses per time, low energy under 0.3 mJ/mm^2, tolerable range |
Device: Extracorporeal shockwave therapy
Extracorporeal shockwave therapy 6 times during 2 weeks
|
Sham Comparator: Control group Sham therapy |
Device: Extracorporeal shockwave therapy
Extracorporeal shockwave therapy 6 times during 2 weeks
|
Outcome Measures
Primary Outcome Measures
- Numerical rating scale (NRS) [Up to 4 weeks (baseline, after each treatment during 2 weeks, 2 weeks + 1 day, 4 weeks)]
Pain intensity (0-10, ordinal scale)
Secondary Outcome Measures
- Shoulder Pain and Disability Index (SPADI) [Up to 4 weeks (baseline, 2 weeks + 1 day, 4 weeks)]
Scoring scale consist of 5 pain scale and 8 disability scale, in %, 0 (best) to 100 (worst)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Brain damaged patient confirmed in the brain image
-
1 month after brain damage
-
Pain in hemiplegic shoulder areas more than 4 points on the numerical scale (NRS)
-
Cognitive functions that can clearly point out NRS with more than 15 points in the mini mental state examination (MMSE)
-
Age: 20 and older
-
Person who has agreed in writing to decide his or her participation and comply with the precautions
Exclusion Criteria:
-
Pain due to trauma
-
Injection treatments two weeks before participating in the study
-
Severe coagulopathy (excluding antiplatelet use)
-
Impaired cognition
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Department of Rehabilitation Medicine, CHA Bundang Medical Center | Seongnam | Korea, Republic of | 13496 |
Sponsors and Collaborators
- Bundang CHA Hospital
Investigators
- Principal Investigator: MinYoung Kim, MD, PhD, Department of Rehabilitation Medicine, CHA Bundang Medical Center, CHA University School of Medicine
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ESWTbraindamage